Biotechnology company VistaGen Therapeutics is on the cusp of revolutionizing drug development with its Human Clinical Trials in a Test Tube™, a versatile stem cell technology platform that brings human biology to the frontend of the drug development process. VistaGen … Continue reading →

VistaGen has developed a stem cell technology platform based on the controlled transformation of human pluripotent stem cells into mature human cells, which can then be used to create bioassay systems to provide clinically relevant predictions on the toxicity and … Continue reading →

VistaGen is a biotech small-cap applying its stem cell technology to revive once-promising drug candidates that were shelved due to heart and liver safety concerns. Pharmaceutical companies spend millions of dollars and decades of time researching new drug candidates to … Continue reading →

The U.S. FDA in August announced its approval for clinical trials using autologous neural stem cells in the treatment of multiple sclerosis (MS), a chronic autoimmune disease affecting roughly 2.1 million people around the world. The disease damages the central … Continue reading →

Biotechnology company VistaGen Therapeutics is engaged in applying human pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism screening. The company’s innovations are advancing drug development by predicting toxicity and other human response to new drug candidates … Continue reading →

The pharmaceutical industry’s current drug development paradigm is supposed to assess whether a drug candidate is both safe and effective for use in the treatment of a given disease. It’s an approach that has been used for many years, involving … Continue reading →

The magic of stem cells is that, in addition to regenerating themselves, they can also generate the specialized operational cells that make up our body. Researchers are learning that there are many types of stem cells, with different functions, and … Continue reading →

In collaboration with Dr. Gordon Keller, one of the world’s leading stem cell researchers, biotech company VistaGen Therapeutics is developing a novel human liver cell-based bioassay system, LiverSafe3D™. VistaGen believes it can use its technology to provide clinically relevant biological … Continue reading →

VistaGen is a biotech company applying human pluripotent stem cell technology for drug rescue and regenerative cell therapy. The company’s drug rescue program involves combining this stem cell technology with the latest medicinal chemistry to create new chemical variants of … Continue reading →

VistaGen Therapeutics is applying its innovative stem cell technologies in two separate but related fields. On the one hand, the company has developed one of the most important new approaches to the field of drug testing in decades, the use … Continue reading →